Nanovis news
First use of a nanotechnology enhanced pedicle screw with label claims to increase and accelerate human osteoblast and mesenchymal stem cell calcified extracellular matrix production in vitro
CARMEL, Ind., Sept. 28, 2021 - Nanovis, an award winning technology company with unique and differentiated nanotechnology surfaces for improving
Carmel, Indiana (July 14, 2020) – Nanovis, a unique technology company focused on nanotechnology for improving bone growth and fighting infection, today reported a record sales month in June 2020.
“I am inspired by the commitment and care demonstrated by our customers and our Nanovis Team in helping a record number of patients with Nanovis implants in June while also doing their part to fight the Covid-19 pandemic.
Nanovis
CARMEL, Indiana (April 29, 2020) – Nanovis today announced that it received 510(k) clearance for a bioceramic nanotube surface on its Nano FortiFix Pedicle Screw System. “Nanovis continues to advance innovative technology platforms to improve patient care. We are very pleased to receive the first FDA clearance for a nanotechnology enhanced pedicle screw system. This technology uniquely offers comparative data in the label assessing the re
CARMEL, Indiana. (July 30, 2019) – Nanovis today announced the commercial launch of its bioceramic nanotube enhanced FortiCore interbodies following a successful alpha launch.
The FortiCore interbodies are designed with a unique, proprietary, patent protected bio-ceramic enhanced titanium nanotube surface. The nanotubes are applied to a deeply porous, fully interconnected titanium scaffold inter
CARMEL, Indiana. (May 8, 2019) – Nanovis today announced that MedTech Outlook recognized Nanovis as a Top 10 Orthopedic Solution Provider, 2019. Its industry-leading fixation technologies offer surgeons and hospitals the best aspects of fixation, visualization, and durability. Nanovis’ developmental infection technology platforms promise to offer surgeons and hospitals much-needed bactericidal solutions.
"A distinguish
CARMEL, Ind., November 14, 2018— Nanovis, a leader in nanomedicine for the spine, today announced adding 22mm and 25mm lengths to its FortiCore® rotatable Posterior Lumbar Interbody Fusion (PLIF) devices.
With over 5,000 FortiCore interbodies now implanted, Nanovis plans to further accelerate its technology driven growth with the expansion of their FortiCore PLIF product line with the addition of 22 mm and 25 mm lengths that ca
CARMEL, Indiana. – Sept. 11, 2018 – Nanovis, a leader in nanomedicine for the spine, today announced a licensing agreement with the University of Nevada, Reno for a key nanosurface technology patent covering the use of ceramics on implants with nanopores.
This foundational patent allows development of ceramics for medical implants with nanosurfacing that enhances cell binding and drug delivery depending on the purpose of implantation.